A novel signature based on microvascular invasion predicts the recurrence of HCC
Abstract Background and objectives In hepatocellular carcinoma (HCC) patients, microvascular invasion (MVI) is associated with worse outcomes regardless of treatment. No single reliable preoperative factor exists to predict MVI. The aim of the work described here was to develop a new MVI− based mRNA...
Main Authors: | Binbin Du, Fang Wang, Beers Jarad, Zhihui Wang, Yanzhou Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-020-02432-7 |
Similar Items
-
Development and clinical validation of a novel platelet count-based nomogram for predicting microvascular invasion in HCC
by: Wenjie Zheng, et al.
Published: (2025-02-01) -
Noninvasive urinary protein signatures combined clinical information associated with microvascular invasion risk in HCC patients
by: Yaru Wang, et al.
Published: (2023-12-01) -
Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion
by: Changcheng Tao, et al.
Published: (2024-01-01) -
Early prediction of microvascular invasion (MVI) occurrence in hepatocellular carcinoma (HCC) by 18F-FDG PET/CT and laboratory data
by: Tianyi Wang, et al.
Published: (2024-07-01) -
Correspondence to editorial on “Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging”
by: Haeryoung Kim, et al.
Published: (2024-10-01)